New study reveals inconsistent care in EMS systems across the United States

Emergency medical service (EMS) systems are not consistently providing optimal care based on new national standards of quality to patients who call 911, according to a new study from the Icahn School of Medicine of Mount Sinai.

Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity – Biotech Investments

Biophytis / Key word(s): Miscellaneous/Miscellaneous Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity 10-Jun-2024 /

June 11, 2024

Worldwide 2024 elections pose pivotal shifts in life sciences and healthcare – Pharmaceutical Technology

Life sciences analysts discussed the sector’s future following US, EU, and UK elections at the Jefferies London Healthcare Conference 2024. Credit: Frankie Fattorini/GlobalData The outcomes

November 21, 2024

Mainz Biomed Reports Full Year 2023 Financial Results – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Annual Results 09.04.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz

April 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.